Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CASI Pharmaceuticals (CASI)
NASDAQ:CASI
CASI Pharmaceuticals (CASI) Stock Price & Analysis
424 Followers
CASI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.85 - $8.48
Previous Close$2.6
Volume10.61K
Average Volume (3M)209.04K
Market Cap
$34.84M
Enterprise Value$22.97M
Total Cash (Recent Filing)$30.77M
Total Debt (Recent Filing)$18.89M
Price to Earnings (P/E)-0.9
Beta1.02
Next Earnings
May 20, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.02
Shares Outstanding13,378,175
10 Day Avg. Volume55,556
30 Day Avg. Volume209,043
Standard Deviation0.25
R-Squared0.03
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.56
Price to Sales (P/S)0.86
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.67
Enterprise Value/Gross Profit0.87
Enterprise Value/Ebitda-0.84
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CASI Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CASI FAQ
What was CASI Pharmaceuticals’s price range in the past 12 months?
CASI Pharmaceuticals lowest stock price was $1.85 and its highest was $8.48 in the past 12 months.
What is CASI Pharmaceuticals’s market cap?
Currently, no data Available
When is CASI Pharmaceuticals’s upcoming earnings report date?
CASI Pharmaceuticals’s upcoming earnings report date is May 20, 2024 which is in 34 days.
How were CASI Pharmaceuticals’s earnings last quarter?
CASI Pharmaceuticals released its earnings results on Mar 28, 2024. The company reported -$0.45 earnings per share for the quarter, missing the consensus estimate of -$0.24 by -$0.21.
Is CASI Pharmaceuticals overvalued?
According to Wall Street analysts CASI Pharmaceuticals’s price is currently Overvalued.
Does CASI Pharmaceuticals pay dividends?
CASI Pharmaceuticals does not currently pay dividends.
What is CASI Pharmaceuticals’s EPS estimate?
CASI Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CASI Pharmaceuticals have?
CASI Pharmaceuticals has 13,401,375 shares outstanding.
What happened to CASI Pharmaceuticals’s price movement after its last earnings report?
CASI Pharmaceuticals reported an EPS of -$0.45 in its last earnings report, missing expectations of -$0.24. Following the earnings report the stock price went up 20.333%.
Which hedge fund is a major shareholder of CASI Pharmaceuticals?
Among the largest hedge funds holding CASI Pharmaceuticals’s share is Consonance Capital. It holds CASI Pharmaceuticals’s shares valued at N/A.
---
CASI Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 156.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.96%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-21.79%
Trailing 12-Months
Company Description
CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
---
CASI Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering CASI
1 Year
1 Year Success Rate
2/15 ratings generated profit
1 Year Average Return
-34.26%
reiterated a buy rating 5 months ago
Copying Sean Lee CFA's trades and holding each position for 1 Year would result in 13.33% of your transactions generating a profit, with an average return of -34.26% per trade.
---